Jefferies analyst Kevin Grundy raised the firm’s price target on Clorox to $145 from $140 and keeps a Hold rating on the shares ahead of the company’s report due on Thursday, February 2. The firm, which expects "modest" sales and earnings upside and believes Clorox is "facing a lower bar" than its Household & Personal Care Products peers, predicts the company will lift the low-end of its FY23 organic sales growth guidance and earnings outlook.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CLX: